Women's Health Weekly

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Women's Health Weekly


We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Cancer Staging

Patients with IQ tumors and vulnerable to understaging benefit from F-18-FDG PET

According to recent research from the United States, "Extraaxillary metastases (i.e., in the absence of axillary involvement) are more likely to develop in patients with IQ breast cancer than in patients with outer-quadrant (OQ) primary tumors. The relative difficulty of identifying extraaxillary metastases may lead to understaging of cancer in these patients."

"This study examined whether F-18-FDG PET findings were differentially associated with the location of primary tumors, and with long-term prognosis,...

• View Other Issues of Women's Health Weekly
  
• View Other NewsRx Publications